Table 4.
Treatment Outcome | ||
---|---|---|
Success | Failure | |
Sexa | ||
Male | 37 (75.5) | 12 (24.5) |
Female | 30 (88.2) | 4 (11.8) |
Locationa | ||
Metaphysis | 99 (84.6) | 18 (15.4) |
Diaphysis | 6 (100.0) | 0 (0) |
Activitya | ||
Active | 30 (75.0) | 10 (25.0) |
Latent | 16 (84.2) | 3 (15.8) |
Treatment | ||
Surgical curettage | 63 (81,1) | 14 (18.2) |
No graft | 13 (76.5) | 4 (23.5) |
Allograft | 15 (88.2) | 2 (11.8) |
Autograft | 18 (78.3) | 5 (21.7) |
Ceramic | 7 (100) | 0 (0) |
Osteoset pellets | 6 (85.7) | 1 (14.3) |
Injection | ||
MPA | 46 (76.7) | 14 (23.3) |
Bone marrow | 10 (76.9) | 3 (23.1) |
Bone marrow + DBM | 10 (100) | 0 (0) |
IM nail | 32 (97.0) | 1 (3.0) |
Screws | 2 (40.0) | 3 (60.0) |
Cyst excision | 2 (100) | 0 (0) |
Conservative | 7 (63.3) | 4 (36.4) |
Metaphysis | 4 (50.0) | 4 (50.0) |
Data were retrieved from these references: [6, 8, 9, 12, 13, 15, 20, 21, 24, 25, 27, 30, 31, 38, 42–46, 54, 61]
MPA methylprednisolone, DBM demineralized bone matrix, IM nail Intramedulary nail, Screws continuous decompression with cannulated screws
aThe exact location of the cyst was not determined in all the papers; therefore, the percentages did not add up to 100 %